The shuttle walk exercise test in idiopathic pulmonary fibrosis

被引:27
|
作者
Moloney, ED
Clayton, N
Mukherjee, DK
Gallagher, CG
Egan, JJ
机构
[1] Univ Coll Dublin, Mater Misericordiae Hosp, Dept Resp Med, Dublin 2, Ireland
[2] Univ Coll Dublin, St Vincents Univ Hosp, Dept Resp Med, Dublin 2, Ireland
[3] S Manchester Univ Hosp NHS Trust, Wythenshawe Hosp, NW Lung Ctr, Manchester, Lancs, England
关键词
shuttle walk exercise test; idiopathic pulmonary fibrosis;
D O I
10.1053/rmed.2003.1501
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The shuttle walk test (SWT) is a validated, incremental walking test for chronic obstructive pulmonary disease, but not for idiopathic pulmonary fibrosis (IPF). The measurement of maximal oxygen consumption (VO2 max) is considered to be the gold standard measurement of functional capacity. This study examines the relationship between IPF patients' performance on the SWT and VO2 max. Twenty patients were recruited for the study, which consisted of two separate experiments. Firstly, the relationship between SWT performance on a conventional corridor SWT with that on a programmable treadmill SWT designed to reproduce the corridor SWT was examined (n = 10). In the second experiment, the relationship between performance on the treadmill equivalent SWT and VO2 max measurements was studied (n = 10). There was a significant correlation between distance walked on the corridor SWT and that walked on the treadmill equivalent SWT without VO2 max measurements (367 m vs 410 m) (r=0.91, P=0.0003),There was a significant correlation between distance walked on the treadmill equivalent SWT (277 m), and the directly determined VO2 max (14.87 ml/kg/min) (r=0.74, P=0.01). During both experiments, a significant correlation was also observed between baseline PaO2 and SWT performance, and between DLCO and SWT performance. The shuttle walk test is a simple objective measure of functional capacity in IPF patients, which should facilitate the evaluation of new therapeutic compounds for IPF. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:682 / 687
页数:6
相关论文
共 50 条
  • [21] Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: Comparison with COPD
    Nishiyama, Osamu
    Taniguchi, Hiroyuki
    Kondoh, Yasuhiro
    Kimura, Tomoki
    Kato, Keisuke
    Ogawa, Tomoya
    Watanabe, Fumiko
    Arizono, Shinichi
    RESPIRATORY MEDICINE, 2007, 101 (04) : 833 - 838
  • [22] Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis
    Lancaster, Lisa
    Fieuw, Ann
    Meulemans, Joyce
    Ford, Paul
    Nathan, Steven D.
    CONTEMPORARY CLINICAL TRIALS, 2021, 100
  • [23] Distance in the six-minute walk test and survival in idiopathic pulmonary fibrosis in Brazil
    Mancuzo, Eliane Viana
    Soares, Maria Raquel
    de Castro Pereira, Carlos Alberto
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2018, 44 (04) : 267 - 272
  • [24] Validity, responsiveness and minimum clinically important difference of the incremental shuttle walk in idiopathic pulmonary fibrosis: a prospective study
    Nolan, Claire M.
    Delogu, Veronica
    Maddocks, Matthew
    Patel, Suhani
    Barker, Ruth E.
    Jones, Sarah E.
    Kon, Samantha S. C.
    Maher, Toby M.
    Cullinan, Paul
    Man, William D-C
    THORAX, 2018, 73 (07) : 680 - 682
  • [25] Six-minute Walk Test: Clinical Significance in Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis
    Kim, M.
    Lee, J.
    Kwak, H.
    Kim, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [26] Exercise training in idiopathic pulmonary fibrosis
    Vainshelboim, Baruch
    Fox, Benjamin Daniel
    Oliveira, Jose
    Kramer, Mordechai Reuven
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (01) : 69 - 77
  • [27] Use of the Modified Shuttle Walk Test During Inpatient Pediatric Cystic Fibrosis Pulmonary Exacerbation Treatment
    Paranjape, Shruti M.
    Carson, Kathryn A.
    Demissie, Seifu M.
    Loosen, Holly
    Vela, Kerry
    Mogayzel, Peter J., Jr.
    JOURNAL OF ACUTE CARE PHYSICAL THERAPY, 2018, 9 (03) : 136 - 142
  • [28] Sildenafil improves walk distance in idiopathic pulmonary fibrosis
    Collard, Harold R.
    Anstrom, Kevin J.
    Schwarz, Marvin I.
    Zisman, David A.
    CHEST, 2007, 131 (03) : 897 - 899
  • [29] Incremental shuttle walk test as an indicator of decreased exercise tolerance in patients with chronic obstructive pulmonary disease
    Hodonska, Jana
    Neumannova, Katerina
    Svoboda, Zdenek
    Sedlak, Vratislav
    Zatloukal, Jaromir
    Plutinsky, Marek
    Koblizek, Vladimir
    Bizovska, Lucia
    ACTA GYMNICA, 2016, 46 (03) : 117 - 121
  • [30] Optimizing exercise performance with a continuously paced shuttle walk test for patients with chronic obstructive pulmonary disease
    Rosa, Fernanda Warken
    Camelier, Aquiles Assungao
    Mayer, Anamaria Fleig
    Jardim, Jose Roberto
    ARCHIVOS DE BRONCONEUMOLOGIA, 2006, 42 (07): : 338 - 343